Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities

An observational study

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.

Original languageEnglish (US)
JournalInquiry (United States)
Volume55
DOIs
StatePublished - Jan 1 2018

Fingerprint

Medication Therapy Management
Patient Protection and Affordable Care Act
Medicare
Social Change
Observational Studies
Hispanic Americans
Confidence Intervals
Ethnic Groups
Odds Ratio

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

@article{e3da7382611648d7bff69aff8b3686a8,
title = "Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities: An observational study",
abstract = "The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95{\%} confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95{\%} CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9{\%} and 17{\%} higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.",
author = "Yanru Qiao and Christina Spivey and Junling Wang and Shih, {Ya Chen Tina} and Jim Wan and Julie Kuhle and Samuel Dagogo-Jack and William Cushman and Marie Chisholm-Burns",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/0046958018795749",
language = "English (US)",
volume = "55",
journal = "Inquiry (United States)",
issn = "0046-9580",
publisher = "Excellus Health Plan",

}

TY - JOUR

T1 - Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities

T2 - An observational study

AU - Qiao, Yanru

AU - Spivey, Christina

AU - Wang, Junling

AU - Shih, Ya Chen Tina

AU - Wan, Jim

AU - Kuhle, Julie

AU - Dagogo-Jack, Samuel

AU - Cushman, William

AU - Chisholm-Burns, Marie

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.

AB - The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.

UR - http://www.scopus.com/inward/record.url?scp=85056391200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056391200&partnerID=8YFLogxK

U2 - 10.1177/0046958018795749

DO - 10.1177/0046958018795749

M3 - Article

VL - 55

JO - Inquiry (United States)

JF - Inquiry (United States)

SN - 0046-9580

ER -